Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Using a new brain‐derived neurotrophic factor (BDNF) specific enzyme‐immunoassay, we determined the basal cellular content of BDNF protein in neonatal rat astrocytes in primary culture, thus confirming the ability of astrocytes to synthesize BDNF in addition to nerve growth factor (NGF). We subsequently monitored the influence of different pharmacological agents: neurotransmitter receptor agonists, cytokines, and second messenger up‐regulators, on the synthesis of BDNF and NGF. Marked differences in the regulation of their synthesis by the above pharmacological agents were observed in our study. The basal cellular levels of BDNF protein in cultured neonatal rat cortical and cerebellar astrocytes were 15.9±0.3 and 18.7±0.4 pg BDNF/mg cell protein, respectively, and differ significantly between astrocytes from different brain regions, whereas NGF levels were the same (16.1±0.3 and 16.2±0.7 pg NGF/mg cell protein, respectively). Screening different neurotransmitter systems for their influence on BDNF and NGF synthesis in cortical astrocytes revealed that dopamine (0.15 mM) is a potent up‐regulator of BDNF protein synthesis in astrocytes, while kainic acid (50 μM) and histamine (1 μM) did not raise the cellular level of BDNF protein. Dopamine had no influence on NGF synthesis, while kainic acid caused minor, and histamine marked, elevation of NGF cellular content. Tumor necrosis factor‐α (30 ng/ml) and interleukin‐1β (10 U/ml) treatments did not influence BDNF synthesis, whereas they markedly increased NGF protein cellular level. We also confirmed (using forskolin (20 μM) and phorbol 12‐myristate 13‐acetate (TPA) (100 nM)) that adenylate cyclase and protein kinase C participate in the downstream signaling responsible for the stimulation of BDNF synthesis, whereas in the regulation of NGF synthesis only the participation of protein kinase C was confirmed. Our results indicate that astrocyte‐derived neurotrophins could play a role in distinct brain functions under physiological conditions and in the pathogenesis as well as possible treatment of different neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 1×
“Astrocytes as a part of a tripartite synapse are intimately involved in synaptic neurotransmission and in the control of neuronal activity (Araque et al., 1999).”
BackgroundPurification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822 · cited 1×
“Brain-derived neurotrophic factor (BDNF) (Barde et al., 1982) and nerve growth factor (NGF) (Levi-Montalcini and Hamburger, 1951) are members of the neurotrophin (NT) gene family of neurotrophic factors, which plays a crucial role in survival, differentiation, phenotypic maintenance, and in the…”
BackgroundNEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337 · cited 2×
“Astrocytic BDNF may also be a promising candidate for a molecular mediator of synaptic plasticity (McAllister et al., 1999).”
BackgroundZafra, F., Hengerer, B., Leibrock, J., Thoenen, H., & Lindholm, D. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07564.x · Cited by 897 · cited 3×
“…and in vivo, where, among glutamate receptor agonists, KA has been shown to be the most potent up-regulator of BDNF mRNA expression in neurons (Zafra et al., 1990, 1991, 1992; Thoenen et al., 1991; Gwag and Springer, 1993; Berninger et al., 1995; Rudge et al., 1995; Marini et al., 1998; Heese…”
BackgroundMurer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · cited 3×
“In patients with PD, a decreased BDNF immunoreactivity level in the substantia nigra is observed ( Murer et al., 2001).”
BackgroundInfluentialLight regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex.
Castrén, E., Zafra, F., Thoenen, H., & Lindholm, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9444 · Cited by 513 · cited 1×
“…BDNF and NGF are predominantly produced by neurons, where the amounts of BDNF and NGF transcripts as well as secreted proteins are regulated by neuronal activity (Castrén et al., 1992; Lindholm et al., 1994; Thoenen, 1995; Tongiorgi et al., 1997; Balkowiec and Katz, 2000; Lever et al., 2001).”
BackgroundZafra, F., Lindholm, D., Castren, E., Hartikka, J., & Thoenen, H. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-12-04793.1992 · Cited by 414
Ferrer, I., Krupinski, J., Goutan, E., Martí, E., Ambrosio, S., & Arenas, E. (2001) · Acta Neuropathologica · doi:10.1007/s004010000268 · Cited by 153
Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., & Kuno, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02098-5 · Cited by 145 · cited 1×
“…1997) and neuroprotective agents such as 4-methylcatechol (Nitta et al., 1999), selegiline and desmethylselegiline (Mizuta et al., 2000), riluzole (Mizuta et al., 2001), Semax (Met-Glu-His-Phe-ProGly-Pro) (Shadrina et al., 2001) andR-(−)-1-(benzofuran2-yl)-2-propylaminopentane (Ohta et al., 2002).”
BackgroundShadrina, M. I., Dolotov, O. V., Grivennikov, I. A., Slominsky, P. A., Andreeva, L. A., Inozemtseva, L. S., Limborska, S. A., & Myasoedov, N. F. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01994-2 · Cited by 46 · cited 1×
“…1997) and neuroprotective agents such as 4-methylcatechol (Nitta et al., 1999), selegiline and desmethylselegiline (Mizuta et al., 2000), riluzole (Mizuta et al., 2001), Semax (Met-Glu-His-Phe-ProGly-Pro) (Shadrina et al., 2001) andR-(−)-1-(benzofuran2-yl)-2-propylaminopentane (Ohta et al., 2002).”
Background
Cited by
The IL-1β system in epilepsy-associated malformations of cortical development
Ravizza, T., Boer, K., Redeker, S., Spliet, W. G. M., van Rijen, P. C., Troost, D., Vezzani, A., & Aronica, E. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.003 · Cited by 268
Up-regulation of BDNF in Astrocytes by TNF-α: A Case for the Neuroprotective Role of Cytokine
Saha, R. N., Liu, X., & Pahan, K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9020-8 · Cited by 257
Sarchielli, P., Mancini, M. L., Floridi, A., Coppola, F., Rossi, C., Nardi, K., Acciarresi, M., Pini, L. A., & Calabresi, P. (2007) · The Journal of Pain · doi:10.1016/j.jpain.2007.05.002 · Cited by 155
Fahimi, A., Baktir, M. A., Moghadam, S., Mojabi, F. S., Sumanth, K., McNerney, M. W., Ponnusamy, R., & Salehi, A. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1308-8 · Cited by 94
Metadata
- Authors
- Miklič, Š., Jurič, D. M., & Čaman‐Kržan, M.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 22
- Issue
- 3
- Pages
- 119-130
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W1982426018
- Cited by
- 76
- References
- 10
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes. https://app.cochat.ai/papers/10.1016/j.ijdevneu.2004.03.001
- The paper
- Miklič, Š., Jurič, D. M., & Čaman‐Kržan, M. (2004). Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes. International Journal of Developmental Neuroscience. https://doi.org/10.1016/j.ijdevneu.2004.03.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.